 |
|
Chromosomes tell tale of patient's risk for new, future cancer
April 17, 2007LOS ANGELES-Hodgkin's disease survivors who have greater genetic instability in their white blood cells are two-and-a-half times more likely to develop another type of cancer, researchers from The University of Texas M. D. Anderson Cancer Center report at the American Association for Cancer Research annual meeting in Los Angeles April 14-18.
Chromosomal aberrations analyzed by the researchers could potentially be used as a biomarker to predict a person's risk of developing a second primary tumor, both for Hodgkin's disease patients and for those with other types of cancer, says principal investigator Randa El-Zein, Ph.D., associate professor in M. D. Anderson's Department of Epidemiology.
"Hodgkin's disease is a highly treatable cancer of the lymphatic system and many patients do very well. Yet we know that some patients are at risk of developing another type of cancer later on-solid tumors, leukemia or melanoma, for example-and we cannot identify those patients in advance now," El-Zein says.
"We can use this measure of genetic instability to identify patients at high risk and counsel them to continue regular screening for breast, colon and other cancers even after their Hodgkin's disease has disappeared," El-Zein says. "We also can emphasize that they should especially avoid tobacco use or exposure to environmental toxins at work and eat a healthy diet. You're at risk, don't do anything to make it worse."
The research team looked at 252 adults treated for Hodgkin's disease at M. D. Anderson between 1986 and 1992. The patients had cytogenetic analysis-a close look at the chromosomes in their lymphocytes-done before treatment began and periodically throughout their care.
"We found that people with a higher level of chromosomal aberrations are the ones who developed a second primary tumor," El-Zein notes. The team measured chromosomal breaks per 100 cells and found patients who developed a second primary cancer had 5.91 breaks per 100 cells while those who did not develop a second tumor had 3.97 breaks per 100.
Over a median follow-up period of 13 years, 27 of the patients developed second cancers: five solid tumors, four leukemias, 11 skin cancers and seven lymphomas. Those with higher chromosomal breaks were 2.48 to 2.78 times more likely to develop cancer anew.
Chromosomal breaks occur when both chromosome arms are truncated. Chromatid breaks are those when only one chromosome arm is shortened, yet these appear to be the more predictive type of break, the researchers found.
"Whatever can be applied to Hodgkin's can be applied to other cancers," El-Zein said, so chromosomal screening has potentially broad application for gauging second primary cancer risk across types of cancer. The team is also analyzing chromosomal breaks for correlations to a patient's response to treatment.
El-Zein presented an abstract of the group's research at the AACR annual meeting and her work was highlighted by the research group in a news conference today.
University of Texas M. D. Anderson Cancer Center
"We can use this measure of genetic instability to identify patients at high risk and counsel them to continue regular screening for breast, colon and other cancers even after their Hodgkin's disease has disappeared," El-Zein says. "We also can emphasize that they should especially avoid tobacco use or exposure to environmental toxins at work and eat a healthy diet. You're at risk, don't do anything to make it worse."
The research team looked at 252 adults treated for Hodgkin's disease at M. D. Anderson between 1986 and 1992. The patients had cytogenetic analysis-a close look at the chromosomes in their lymphocytes-done before treatment began and periodically throughout their care.
"We found that people with a higher level of chromosomal aberrations are the ones who developed a second primary tumor," El-Zein notes. The team measured chromosomal breaks per 100 cells and found patients who developed a second primary cancer had 5.91 breaks per 100 cells while those who did not develop a second tumor had 3.97 breaks per 100.
Over a median follow-up period of 13 years, 27 of the patients developed second cancers: five solid tumors, four leukemias, 11 skin cancers and seven lymphomas. Those with higher chromosomal breaks were 2.48 to 2.78 times more likely to develop cancer anew.
Chromosomal breaks occur when both chromosome arms are truncated. Chromatid breaks are those when only one chromosome arm is shortened, yet these appear to be the more predictive type of break, the researchers found.
"Whatever can be applied to Hodgkin's can be applied to other cancers," El-Zein said, so chromosomal screening has potentially broad application for gauging second primary cancer risk across types of cancer. The team is also analyzing chromosomal breaks for correlations to a patient's response to treatment.
El-Zein presented an abstract of the group's research at the AACR annual meeting and her work was highlighted by the research group in a news conference today.
University of Texas M. D. Anderson Cancer Center
Cancer News and Current Cancer Events RSSBisphenol A linked to metabolic syndrome in human tissue
New research from the University of Cincinnati (UC) implicates the primary chemical used to produce hard plastics-bisphenol A (BPA)-as a risk factor for metabolic syndrome and its consequences.
African-Americans have unique lung cancer risks from chronic obstructive pulmonary disease
Scientists at the M.D. Anderson Cancer Center have developed a risk prediction assessment for lung cancer specifically for African Americans that suggests a greater risk from chronic obstructive pulmonary disease (COPD).
Atomic structure of the mammalian 'fatty acid factory' determined
Mammalian fatty acid synthase is one of the most complex molecular synthetic machines in human cells. It is also a promising target for the development of anti-cancer and anti-obesity drugs and the treatment of metabolic disorders.
International team reveals first prognosticator of survival in aggressive cancer
The tumor suppressor gene pRb2/p130 may provide the first independent prognostic biomarker in cases of soft tissue sarcoma (STS).
M. D. Anderson study finds change in HER2 status after treatment with Herceptin
Researchers at The University of Texas M. D. Anderson Cancer Center have discovered that when treated with Herceptin prior to surgery, 50 percent of HER2 positive, breast cancer patients showed no signs of disease at the time of surgery.
M. D. Anderson study finds racial disparities in radiation therapy rates for breast cancer
Black women are less likely than white women to receive radiation therapy after a lumpectomy, the standard of care for early stage breast cancer, according to a new study by researchers at The University of Texas M. D. Anderson Cancer Center.
NC State Is First University in Nation to Offer Canine Bone Marrow Transplants
Dogs suffering from lymphoma will be able to receive the same type of medical treatment as their human counterparts, as North Carolina State University becomes the first university in the nation to offer canine bone marrow transplants in a clinical setting.
DNA editing tool flips its target
Imagine having to copy an entire book by hand without missing a comma. Our cells face a similar task every time they divide. They must duplicate both their DNA and a subtle pattern of punctuation-like modifications on the DNA known as methylation.
What a Sleep Study Can Reveal About Fibromyalgia
Research engineers and sleep medicine specialists from two Michigan universities have joined technical and clinical hands to put innovative quantitative analysis, signal-processing technology and computer algorithms to work in the sleep lab.
Stem cell research puts interstate rivalry on hold
Victoria and New South Wales have put aside their competitive interstate rivalry to collaborate on a stem cell research project, as announced by Innovation Minister Gavin Jennings and NSW Minister for Science and Medical Research, Verity Firth, today.
More Cancer News Articles
 | The Last Lecture by Randy Pausch, Jeffrey Zaslow "We cannot change the cards we are dealt, just how we play the hand." --Randy Pausch A lot of professors give talks titled "The Last Lecture." Professors are asked to consider their demise and to ruminate on what matters most to them. And while they speak, audiences can't help but mull the same question: What wisdom would we impart to the world if we knew it was our last chance? If we had to... |
 | My Sister's Keeper: A Novel by Jodi Picoult New York Times bestselling author Jodi Picoult is widely acclaimed for her keen insights into the hearts and minds of real people. Now she tells the emotionally riveting story of a family torn apart by conflicting needs and a passionate love that triumphs over human weakness.Anna is not sick, but she might as well be. By age thirteen, she has undergone countless surgeries, transfusions, and shots... |
 | The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health by T. Colin Campbell, Thomas M. Campbell II Referred to as the "Grand Prix of epidemiology" by The New York Times, this study examines more than 350 variables of health and nutrition with surveys from 6,500 adults in more than 2,500 counties across China and Taiwan, and conclusively demonstrates the link between nutrition and heart disease, diabetes, and cancer. While revealing that proper nutrition can have a dramatic effect on reducing... |
 | Eat to Live: The Revolutionary Formula for Fast and Sustained Weight Loss by Joel Fuhrman When Mehmet Oz or any of New York's leading doctors has a patient whose life depends on losing weight, they call on Joel Fuhrman, M.D. In EAT TO LIVE, Dr. Fuhrman offers his healthy, effective, and scientifically proven plan for shedding radical amounts of weight quickly, and keeping it off.Losing weight under Dr. Fuhrman's plan is not about willpower, it is about knowledge. The key to this... |
 | Silent Spring by Rachel Carson Silent Spring, released in 1962, offered the first shattering look at widespread ecological degradation and touched off an environmental awareness that still exists. Rachel Carson's book focused on the poisons from insecticides, weed killers, and other common products as well as the use of sprays in agriculture, a practice that led to dangerous chemicals to the food source. Carson argued that... |
 | It's Not About the Bike: My Journey Back to Life by Lance Armstrong, Sally Jenkins People around the world have found inspiration in the story of Lance Armstrong--a world-class athlete nearly struck down by cancer, only to recover and win the Tour de France, the multiday bicycle race famous for its grueling intensity. Armstrong is a thoroughgoing Texan jock, and the changes brought to his life by his illness are startling and powerful, but he's just not interested in wearing a... |
 | Anticancer: A New Way of Life by David Servan-Schreiber A radical synthesis of science and personal experience that advocates a sea change in the way we understand and confront cancerWhen David Servan- Schreiber, a dedicated scientist and doctor, was diagnosed with brain cancer, it changed his life. Confronting what medicine knows about the illness, the little known workings of the body’s natural cancer-fighting capacities, and his own will to live,... |
 | Courageous Souls: Do We Plan Our Life Challenges Before Birth? by Robert Schwartz Courageous Souls explores the premise that we are all eternal souls who plan our lives, including our greatest challenges, before we re born for purposes of spiritual growth. The book contains ten true stories of people who planned physical illness, having handicapped children, deafness, blindness, drug addiction, alcoholism, losing a loved one, and severe accidents. Because very different life... |
 | Good Calories, Bad Calories by Gary Taubes In this groundbreaking book, the result of seven years of research in every science connected with the impact of nutrition on health, award-winning science writer Gary Taubes shows us that almost everything we believe about the nature of a healthy diet is wrong.For decades we have been taught that fat is bad for us, carbohydrates better, and that the key to a healthy weight is eating less and... |
 | Autobiography of a Face by Lucy Grealy At age nine, Lucy Grealy was diagnosed with a potentially terminal cancer. When she returned to school with a third of her jaw removed, she faced the cruel taunts of classmates. In this strikingly candid memoir, Grealy tells her story of great suffering and remarkable strength without sentimentality and with considerable wit. Vividly portraying the pain of peer rejection and the guilty... |
| © 2008 BrightSurf.com |